v3.26.1
Condensed Statement of Changes in Shareholders’ Deficit (Unaudited) - 3 months ended Mar. 31, 2026 - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 [1] $ 719 $ 24,281 $ (59,134) $ (34,134)
Balance (in Shares) at Dec. 31, 2025 [1] 7,187,500      
Proceeds from Private Placement Warrants, less issuance costs 11,776 11,776
Proceeds from sale of Public Warrants, less issuance costs 1,624,899 1,624,899
Proceeds from sale of Private Placement shares, less issuance costs $ 20 1,984,058 1,984,078
Proceeds from sale of Private Placement shares, less issuance costs (in Shares) 200,000      
Accretion of Class A ordinary shares subject to redemption to redemption value $ 0 $ 0 3,645,014 15,896,516 19,541,530
Net Income 1,688,089 1,688,089
Balance at Mar. 31, 2026 $ 20 $ 719 $ (14,267,561) $ (14,266,822)
Balance (in Shares) at Mar. 31, 2026 200,000 7,187,500      
[1] Includes 937,500 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (Note 6). On January 15, 2026, the underwriters exercised their over-allotment option in full. As a result, 937,500 Class B ordinary shares are no longer subject to forfeiture.